Having trouble viewing this email? View in your browser.
ESCMID Logo

23 August 2016
WEEKLY NEWS

Dear colleagues,

The society published a press release on the update of its guidelines on the diagnosis of Clostridium difficile. You may find all of ESCMID’s guidelines on the dedicated page.

Best regards, your ESCMID communications editors

 

UN general assembly to discuss antimicrobial resistance next month

Antimicrobial resistance is finally on the agenda at the high-level United Nations General Assembly, which will take place on 21 September in New York. This will be only the fourth health issue – and the first One Health issue integrating human, animal, and environmental health – bringing together heads of state to set a global agenda. We encourage experts within the ESCMID network to urge their governments to support a strong resolution on AMR. We would like the UN assembly to set targets for reduction of antimicrobial use and resistance both in human and animal sectors; to define the governance to address AMR and make a commitment to funding for a global action. More detail and background information can be found on the WHO website. An article in Science on the topic is available for subscribers only.

› Read more
 

CMI highlight: Point-of-care trials & informed consent

Researchers from Switzerland, Austria and Israel reviewed point-of-care randomization and informed consent in clinical trials. For low-risk trials whose purpose is to evaluate non-experimental therapies or other measures toward which the medical community is in a state of equipoise, ethics committees should play a more active role in a more standardized fashion, the authors write. Patients in the clinic are continually subject to spontaneous “pseudo-randomizations” based on local dogma and the anecdotal experience of their physicians. Stronger ethics oversight would allow point-of-care trials to structure these spontaneous randomizations, using widely available informatics tools, in combination with opt-out informed consent where deemed appropriate.

› Read more
 

Abstracts submission for ECCMID 2017 will start in less than a week

From 29 August until 30 November you will be able to submit your abstracts for ECCMID 2017 in Vienna. If you have questions on the process, you may consult the abstract guidelines, abstract topics or check out the tutorial video on how to submit an abstract for ECCMID.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.